2022
DOI: 10.1007/s12094-022-02991-9
|View full text |Cite
|
Sign up to set email alerts
|

Tumor-suppressive miR-29c binds to MAPK1 inhibiting the ERK/MAPK pathway in pancreatic cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 28 publications
0
2
0
Order By: Relevance
“…Downregulation of miR-29c was detected in clinical PDAC tissues, and this miRNA showed an antitumor function by inhibiting integrin subunit β1 [55]. A recent study showed that miR-29c targets MAPK1 to suppress activation of the ERK/MAPK pathway [56].…”
Section: Discussionmentioning
confidence: 98%
“…Downregulation of miR-29c was detected in clinical PDAC tissues, and this miRNA showed an antitumor function by inhibiting integrin subunit β1 [55]. A recent study showed that miR-29c targets MAPK1 to suppress activation of the ERK/MAPK pathway [56].…”
Section: Discussionmentioning
confidence: 98%
“…Several miRNAs have been suggested to regulate the expression of oncogenes or tumour suppressing genes which ultimately either positively or negatively contribute towards tumour development [ 81 ]. For example, downregulated miR-29c was found in PDAC tissues and was associated with upregulated MAPK1 and resulted in increased cell proliferation, and invasion through activating the downstream MAPK/ERK pathway [ 50 ]. Similarly, downregulated expression of miR-98-5p was shown to lead to upregulated MAP4K4 which promoted cell proliferation, invasion, and migration of PDAC cells in vitro by promoting MAPK/ERK signalling [ 56 ].…”
Section: Mirna Effects On Cell Proliferation and Cell Cycle Progressionmentioning
confidence: 99%